Company intelligence / Profile preview
Nuo Therapeutics
Houston, Texas, United Statesnuot.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Commercial
01
Overview
Nuo Therapeutics has commercialized the Aurix System—a point-of-care device that processes a patient’s own blood to create an autologous platelet-rich gel. Clinical results have demonstrated efficacy in accelerating healing of chronic wounds such as diabetic foot ulcers and venous leg ulcers. The product has established value in hospital outpatient settings.
- Therapeutic areas
- DermatologyCardiovascularImmunology
- Modalities
- DeviceBiologic (autologous platelet and plasma-derived therapy)Cell therapy (autologous blood components)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Nuo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuo Therapeutics.